Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyalgia rheumatica and giant cell arteritis.

J M Evans1, G G Hunder

  • 1Section of Geriatrics, Mayo Clinic, Rochester, Minnesota, USA.

Rheumatic Diseases Clinics of North America
|September 16, 2000
PubMed
Summary

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are linked inflammatory conditions. While corticosteroids are standard treatment, new markers like IL-6 offer better disease activity insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents.

Integrative medicine (Encinitas, Calif.)·2020
Same author

The Functional Medicine Approach to COVID-19: Primer on SARS-CoV-2 Testing.

Integrative medicine (Encinitas, Calif.)·2020
Same author

A multi-method review of home-based chemotherapy.

European journal of cancer care·2015
Same author

Association of DLA-DQB1 alleles with exocrine pancreatic insufficiency in Pembroke Welsh Corgis.

Animal genetics·2015
Same author

13-Year experience in external fixation of the pelvis: complications, reduction and removal.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
Same author

Open distal tibial shaft fractures: a retrospective comparison of medial plate versus nail fixation.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are common, related inflammatory conditions.
  • These diseases are increasingly understood to involve a cellular inflammatory response, potentially triggered by infections in genetically susceptible individuals.
  • Giant cell arteritis (GCA) is now recognized to frequently involve the proximal aorta, not just branch vessels.

Purpose of the Study:

  • To summarize the current understanding of PMR and GCA.
  • To highlight advancements in understanding the pathophysiology and scope of GCA.
  • To discuss current and potential future markers for disease activity.

Main Methods:

  • Review of existing literature on PMR and GCA.
  • Analysis of current evidence regarding disease mechanisms and presentation.
  • Evaluation of diagnostic and monitoring tools.

Main Results:

  • PMR and GCA represent a disease continuum with excellent prognosis despite potential complications.
  • Corticosteroids are the primary treatment but are not curative.
  • Erythrocyte sedimentation rate (ESR) is a useful marker, but C-reactive protein (CRP) and Interleukin-6 (IL-6) may offer more precise disease activity information.

Conclusions:

  • PMR and GCA are significant rheumatologic conditions requiring ongoing management.
  • Understanding the expanded vascular involvement in GCA is crucial for patient care.
  • Further research into inflammatory markers like IL-6 could improve treatment monitoring for these conditions.

Related Experiment Videos